期刊论文详细信息
Frontiers in Oncology 卷:10
Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies
Jesus M. Paramio2  Cristian Suárez-Cabrera2  Marta Duenas2  Lorena Diéguez3  Marta I. Oliveira4  Vânia Grenha5  Mónica Martínez-Fernández6  Ricardo Ribeiro8  Catarina M. Abreu10  Sandra Carvalho10  Paulo P. Freitas10  José A. Ferreira11  Lúcio L. Santos11  Dylan Ferreira11  Luís Lima12 
[1] Microenvironment Group, i3S/INEB, Instituto de Investigação e Inovação em Saúde/Instituto de Engenharia Biomédica, University of Porto, Porto, Portugal;
[2] 0Molecular Oncology Unit, CIEMAT, Madrid, Spain;
[3] 1CIBERONC, Institute of Biomedical Research, University Hospital “12 de Octubre”, Madrid, Spain;
[4] 2International Iberian Nanotechnology Laboratory, Department of Nanoelectronics Engineering, Braga, Portugal;
[5] Departament of Clinical Pathology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal;
[6] Department of Urology, Centro Hospitalar Do Alto Ave, Guimarães, Portugal;
[7] Experimental Pathology and Therapeutics Group, Research Center of the Portuguese Institute of Oncology (CI-IPOP), Porto, Portugal;
[8] Faculty of Medicine, Environmental Health Institute, University of Lisbon, Lisbon, Portugal;
[9] Genomes and Disease Lab., Research Center of Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain;
[10] International Iberian Nanotechnology Laboratory, Department of Life Sciences, Braga, Portugal;
[11] Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal;
[12] School of Health, Polytechnic Institute of Porto, Porto, Portugal;
[13] Tumor &
关键词: bladder cancer;    microfluidics;    liquid biopsy;    urine;    Sialyl-Tn;   
DOI  :  10.3389/fonc.2020.01774
来源: DOAJ
【 摘 要 】

Bladder cancer is the most common malignancy of the urinary tract, having one of the highest recurrence rates and progression from non-muscle to muscle invasive bladder cancer that commonly leads to metastasis. Cystoscopy and urine cytology are the standard procedures for its detection but have limited clinical sensitivity and specificity. Herein, a microfluidic device, the UriChip, was developed for the enrichment of urothelial exfoliated cells from fresh and frozen urine, based on deformability and size, and the cancer-associated glycan Sialyl-Tn explored as a putative bladder cancer urinary biomarker. Spiking experiments with bladder cancer cell lines showed an isolation efficiency of 53%, while clinical sample analyses revealed retention of cells with various morphologies and sizes. in situ immunoassays demonstrated significantly higher number of Sialyl-Tn-positive cells in fresh and frozen voided urine from bladder cancer patients, compared to healthy individuals. Of note, urothelial exfoliated cells from cryopreserved urine sediments were also successfully isolated by the UriChip, and found to express significantly high levels of Sialyl-Tn. Remarkably, Sialyl-Tn expression is correlated with tumor stage and grade. Overall, our findings demonstrate the potential of UriChip and Sialyl-Tn to detect urothelial bladder cancer cells in follow-up and long-term retrospective studies.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次